Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N4O3 |
InChIKeyJSZPIOJRNMIRQD-DOXZYTNZSA-N |
CAS Registry1222372-81-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 01 Jul 2013 |